Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 7 of 7 entries
Sorted by: Best Match Show Resources per page
Organic mercury solid phase chemoselective capture for proteomic identification of S-nitrosated proteins and peptides.

Nitric oxide : biology and chemistry

Doulias PT, Tenopoulou M, Zakopoulos I, Ischiropoulos H.
PMID: 34536587
Nitric Oxide. 2021 Dec 01;117:1-6. doi: 10.1016/j.niox.2021.09.004. Epub 2021 Sep 15.

Cysteine S-nitrosation mediates NO signaling and protein function under pathophysiological conditions. Herein, we provide a detailed protocol regarding the organic mercury chemoselective enrichment of S-nitrosated proteins and peptides. We discuss key aspects of the enrichment strategy and provide technical...

Cite
Doulias PT, Tenopoulou M, Zakopoulos I, et al. Organic mercury solid phase chemoselective capture for proteomic identification of S-nitrosated proteins and peptides. Nitric Oxide. 2021;117:1-6doi: 10.1016/j.niox.2021.09.004.
Doulias, P. T., Tenopoulou, M., Zakopoulos, I., & Ischiropoulos, H. (2021). Organic mercury solid phase chemoselective capture for proteomic identification of S-nitrosated proteins and peptides. Nitric oxide : biology and chemistry, 1171-6. https://doi.org/10.1016/j.niox.2021.09.004
Doulias, Paschalis-Thomas, et al. "Organic mercury solid phase chemoselective capture for proteomic identification of S-nitrosated proteins and peptides." Nitric oxide : biology and chemistry vol. 117 (2021): 1-6. doi: https://doi.org/10.1016/j.niox.2021.09.004
Doulias PT, Tenopoulou M, Zakopoulos I, Ischiropoulos H. Organic mercury solid phase chemoselective capture for proteomic identification of S-nitrosated proteins and peptides. Nitric Oxide. 2021 Dec 01;117:1-6. doi: 10.1016/j.niox.2021.09.004. Epub 2021 Sep 15. PMID: 34536587.
Copy Download .nbib Format: NLM
TCA cycle metabolic compromise due to an aberrant S-nitrosoproteome in HIV-associated neurocognitive disorder with methamphetamine use.

Journal of neurovirology

Doulias PT, Nakamura T, Scott H, McKercher SR, Sultan A, Deal A, Albertolle M, Ischiropoulos H, Lipton SA.
PMID: 33876414
J Neurovirol. 2021 Jun;27(3):367-378. doi: 10.1007/s13365-021-00970-4. Epub 2021 Apr 19.

In the brain, both HIV-1 and methamphetamine (meth) use result in increases in oxidative and nitrosative stress. This redox stress is thought to contribute to the pathogenesis of HIV-associated neurocognitive disorder (HAND) and further worsening cognitive activity in the...

Cite
Doulias PT, Nakamura T, Scott H, et al. TCA cycle metabolic compromise due to an aberrant S-nitrosoproteome in HIV-associated neurocognitive disorder with methamphetamine use. J Neurovirol. 2021;27(3):367-378doi: 10.1007/s13365-021-00970-4.
Doulias, P. T., Nakamura, T., Scott, H., McKercher, S. R., Sultan, A., Deal, A., Albertolle, M., Ischiropoulos, H., & Lipton, S. A. (2021). TCA cycle metabolic compromise due to an aberrant S-nitrosoproteome in HIV-associated neurocognitive disorder with methamphetamine use. Journal of neurovirology, 27(3), 367-378. https://doi.org/10.1007/s13365-021-00970-4
Doulias, Paschalis-Thomas, et al. "TCA cycle metabolic compromise due to an aberrant S-nitrosoproteome in HIV-associated neurocognitive disorder with methamphetamine use." Journal of neurovirology vol. 27,3 (2021): 367-378. doi: https://doi.org/10.1007/s13365-021-00970-4
Doulias PT, Nakamura T, Scott H, McKercher SR, Sultan A, Deal A, Albertolle M, Ischiropoulos H, Lipton SA. TCA cycle metabolic compromise due to an aberrant S-nitrosoproteome in HIV-associated neurocognitive disorder with methamphetamine use. J Neurovirol. 2021 Jun;27(3):367-378. doi: 10.1007/s13365-021-00970-4. Epub 2021 Apr 19. PMID: 33876414; PMCID: PMC8477648.
Copy Download .nbib Format: NLM
The Convergence of Dopamine and α-Synuclein: Implications for Parkinson's Disease.

Journal of experimental neuroscience

Mor DE, Ischiropoulos H.
PMID: 29559809
J Exp Neurosci. 2018 Mar 08;12:1179069518761360. doi: 10.1177/1179069518761360. eCollection 2018.

In Parkinson's disease (PD), the loss of dopamine-producing neurons in the substantia nigra (SN) leads to severe motor impairment, and pathological inclusions known as Lewy bodies contain aggregated α-synuclein protein. The relationship of α-synuclein aggregation and dopaminergic degeneration is...

Cite
Mor DE, Ischiropoulos H. The Convergence of Dopamine and α-Synuclein: Implications for Parkinson's Disease. J Exp Neurosci. 2018;12:1179069518761360doi: 10.1177/1179069518761360.
Mor, D. E., & Ischiropoulos, H. (2018). The Convergence of Dopamine and α-Synuclein: Implications for Parkinson's Disease. Journal of experimental neuroscience, 121179069518761360. https://doi.org/10.1177/1179069518761360
Mor, Danielle E, and Ischiropoulos, Harry. "The Convergence of Dopamine and α-Synuclein: Implications for Parkinson's Disease." Journal of experimental neuroscience vol. 12 (2018): 1179069518761360. doi: https://doi.org/10.1177/1179069518761360
Mor DE, Ischiropoulos H. The Convergence of Dopamine and α-Synuclein: Implications for Parkinson's Disease. J Exp Neurosci. 2018 Mar 08;12:1179069518761360. doi: 10.1177/1179069518761360. eCollection 2018. PMID: 29559809; PMCID: PMC5846926.
Copy Download .nbib Format: NLM
Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle.

Molecular neurodegeneration

Malkus KA, Tsika E, Ischiropoulos H.
PMID: 19500376
Mol Neurodegener. 2009 Jun 05;4:24. doi: 10.1186/1750-1326-4-24.

While numerous hypotheses have been proposed to explain the molecular mechanisms underlying the pathogenesis of neurodegenerative diseases, the theory of oxidative stress has received considerable support. Although many correlations have been established and encouraging evidence has been obtained, conclusive...

Cite
Malkus KA, Tsika E, Ischiropoulos H. Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle. Mol Neurodegener. 2009;4:24doi: 10.1186/1750-1326-4-24.
Malkus, K. A., Tsika, E., & Ischiropoulos, H. (2009). Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle. Molecular neurodegeneration, 424. https://doi.org/10.1186/1750-1326-4-24
Malkus, Kristen A, et al. "Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle." Molecular neurodegeneration vol. 4 (2009): 24. doi: https://doi.org/10.1186/1750-1326-4-24
Malkus KA, Tsika E, Ischiropoulos H. Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle. Mol Neurodegener. 2009 Jun 05;4:24. doi: 10.1186/1750-1326-4-24. PMID: 19500376; PMCID: PMC2701947.
Copy Download .nbib Format: NLM
Correction to: TCA cycle metabolic compromise due to an aberrant S‑nitrosoproteome in HIV‑associated neurocognitive disorder with methamphetamine use.

Journal of neurovirology

Doulias PT, Nakamura T, Scott H, McKercher SR, Sultan A, Deal A, Albertolle M, Ischiropoulos H, Lipton SA.
PMID: 33942273
J Neurovirol. 2021 Jun;27(3):379. doi: 10.1007/s13365-021-00985-x.

No abstract available.

Cite
Doulias PT, Nakamura T, Scott H, et al. Correction to: TCA cycle metabolic compromise due to an aberrant S‑nitrosoproteome in HIV‑associated neurocognitive disorder with methamphetamine use. J Neurovirol. 2021;27(3):379doi: 10.1007/s13365-021-00985-x.
Doulias, P. T., Nakamura, T., Scott, H., McKercher, S. R., Sultan, A., Deal, A., Albertolle, M., Ischiropoulos, H., & Lipton, S. A. (2021). Correction to: TCA cycle metabolic compromise due to an aberrant S‑nitrosoproteome in HIV‑associated neurocognitive disorder with methamphetamine use. Journal of neurovirology, 27(3), 379. https://doi.org/10.1007/s13365-021-00985-x
Doulias, Paschalis-Thomas, et al. "Correction to: TCA cycle metabolic compromise due to an aberrant S‑nitrosoproteome in HIV‑associated neurocognitive disorder with methamphetamine use." Journal of neurovirology vol. 27,3 (2021): 379. doi: https://doi.org/10.1007/s13365-021-00985-x
Doulias PT, Nakamura T, Scott H, McKercher SR, Sultan A, Deal A, Albertolle M, Ischiropoulos H, Lipton SA. Correction to: TCA cycle metabolic compromise due to an aberrant S‑nitrosoproteome in HIV‑associated neurocognitive disorder with methamphetamine use. J Neurovirol. 2021 Jun;27(3):379. doi: 10.1007/s13365-021-00985-x. PMID: 33942273.
Copy Download .nbib Format: NLM
Detection of peroxynitrite in biological fluids.

Methods in molecular medicine

Malcolm S, Foust R, Hertkorn C, Ischiropoulos H.
PMID: 21340973
Methods Mol Med. 2000;36:171-7. doi: 10.1385/1-59259-216-3:171.

Peroxynitrite (ONOO(-)) is both an oxidant and a nitrating agent (1-3). However, unlike other strong oxidants, peroxynitrite reacts selectively with biological targets. This selectivity is derived in part from the different second-order rate constants (vary from 10(3)-10(6) M (-1)...

Cite
Malcolm S, Foust R, Hertkorn C, et al. Detection of peroxynitrite in biological fluids. Methods Mol Med. 2000;36:171-7doi: 10.1385/1-59259-216-3:171.
Malcolm, S., Foust, R., Hertkorn, C., & Ischiropoulos, H. (2000). Detection of peroxynitrite in biological fluids. Methods in molecular medicine, 36171-7. https://doi.org/10.1385/1-59259-216-3:171
Malcolm, S, et al. "Detection of peroxynitrite in biological fluids." Methods in molecular medicine vol. 36 (2000): 171-7. doi: https://doi.org/10.1385/1-59259-216-3:171
Malcolm S, Foust R, Hertkorn C, Ischiropoulos H. Detection of peroxynitrite in biological fluids. Methods Mol Med. 2000;36:171-7. doi: 10.1385/1-59259-216-3:171. PMID: 21340973.
Copy Download .nbib Format: NLM
ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism.

Cancer & metabolism

Khare S, Kim LC, Lobel G, Doulias PT, Ischiropoulos H, Nissim I, Keith B, Simon MC.
PMID: 34861885
Cancer Metab. 2021 Dec 03;9(1):40. doi: 10.1186/s40170-021-00271-8.

BACKGROUND: Kidney cancer is a common adult malignancy in the USA. Clear cell renal cell carcinoma (ccRCC), the predominant subtype of kidney cancer, is characterized by widespread metabolic changes. Urea metabolism is one such altered pathway in ccRCC. The...

Cite
Khare S, Kim LC, Lobel G, et al. ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism. Cancer Metab. 2021;9(1):40doi: 10.1186/s40170-021-00271-8.
Khare, S., Kim, L. C., Lobel, G., Doulias, P. T., Ischiropoulos, H., Nissim, I., Keith, B., & Simon, M. C. (2021). ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism. Cancer & metabolism, 9(1), 40. https://doi.org/10.1186/s40170-021-00271-8
Khare, Sanika, et al. "ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism." Cancer & metabolism vol. 9,1 (2021): 40. doi: https://doi.org/10.1186/s40170-021-00271-8
Khare S, Kim LC, Lobel G, Doulias PT, Ischiropoulos H, Nissim I, Keith B, Simon MC. ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism. Cancer Metab. 2021 Dec 03;9(1):40. doi: 10.1186/s40170-021-00271-8. PMID: 34861885; PMCID: PMC8642968.
Copy Download .nbib Format: NLM
Showing 1 to 7 of 7 entries